Relocalizing transcriptional kinases to activate apoptosis.

Autor: Sarott RC; Department of Chemical and Systems Biology, Stanford University, Stanford, CA 94305, USA., Gourisankar S; Department of Chemical and Systems Biology, Stanford University, Stanford, CA 94305, USA., Karim B; Department of Chemistry, Stanford University, Stanford, CA 94305, USA., Nettles S; Department of Pathology, Stanford University, Stanford, CA 94305, USA., Yang H; Department of Lymphoma & Myeloma, MD Anderson Cancer Center, Houston, TX 77030, USA., Dwyer BG; Department of Chemical and Systems Biology, Stanford University, Stanford, CA 94305, USA., Simanauskaite JM; Department of Pathology, Stanford University, Stanford, CA 94305, USA., Tse J; Department of Chemical and Systems Biology, Stanford University, Stanford, CA 94305, USA., Abuzaid H; Department of Pathology, Stanford University, Stanford, CA 94305, USA., Krokhotin A; Department of Pathology, Stanford University, Stanford, CA 94305, USA., Zhang T; Department of Chemical and Systems Biology, Stanford University, Stanford, CA 94305, USA., Hinshaw SM; Department of Chemical and Systems Biology, Stanford University, Stanford, CA 94305, USA., Green MR; Department of Lymphoma & Myeloma, MD Anderson Cancer Center, Houston, TX 77030, USA., Crabtree GR; Department of Pathology, Stanford University, Stanford, CA 94305, USA.; Department of Developmental Biology, Stanford University, Stanford, CA 94305, USA., Gray NS; Department of Chemical and Systems Biology, Stanford University, Stanford, CA 94305, USA.

Publikováno v: Science (New York, N.Y.) [Science] 2024 Oct 04; Vol. 386 (6717), pp. eadl5361. Date of Electronic Publication: 2024 Oct 04.

Author Correction: Rewiring cancer drivers to activate apoptosis.

Autor: Gourisankar S; Department of Pathology, Stanford University, Stanford, CA, USA.; Department of Chemical Engineering, Stanford University, Stanford, CA, USA., Krokhotin A; Department of Pathology, Stanford University, Stanford, CA, USA., Ji W; Department of Chemical and Systems Biology, Stanford Cancer Institute, ChEM-H, Stanford University, Stanford, CA, USA., Liu X; Department of Chemical and Systems Biology, Stanford Cancer Institute, ChEM-H, Stanford University, Stanford, CA, USA., Chang CY; Department of Pathology, Stanford University, Stanford, CA, USA., Kim SH; Department of Pathology, Stanford University, Stanford, CA, USA., Li Z; Department of Chemical and Systems Biology, Stanford Cancer Institute, ChEM-H, Stanford University, Stanford, CA, USA., Wenderski W; Department of Pathology, Stanford University, Stanford, CA, USA.; Department of Developmental Biology, Stanford University, Stanford, CA, USA., Simanauskaite JM; Department of Pathology, Stanford University, Stanford, CA, USA., Yang H; Department of Lymphoma & Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Vogel H; Department of Pathology, Stanford University, Stanford, CA, USA., Zhang T; Department of Chemical and Systems Biology, Stanford Cancer Institute, ChEM-H, Stanford University, Stanford, CA, USA., Green MR; Department of Lymphoma & Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Gray NS; Department of Chemical and Systems Biology, Stanford Cancer Institute, ChEM-H, Stanford University, Stanford, CA, USA. nsgray01@stanford.edu., Crabtree GR; Department of Pathology, Stanford University, Stanford, CA, USA. crabtree@stanford.edu.; Department of Developmental Biology, Stanford University, Stanford, CA, USA. crabtree@stanford.edu.

Publikováno v: Nature [Nature] 2023 Sep; Vol. 621 (7977), pp. E27.